Jonathan Abbas is an Oncology physician affiliated with Tennessee Oncology. OpenAlex indexes 17 publications with 202 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
322 22nd Ave N Ste 200
Nashville, TN 372031836
Telephone
615-986-7600Provider last certified this registry record 10 Mar 2026.
Industry payments
58 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202532 payments$33,667openpaymentsdata.cms.gov ↗
- Syndax Pharmaceuticals, Inc.Program year202520 payments$28,647openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202531 payments$23,183openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
43.8%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor16.9%Valacyclovir100%Part D≥24 patientsAzole Antifungal16.7%Voriconazole82%Fluconazole18%Part D<11 patients+ 1 more class in this area
Cancer & immunology
33.1%BCL-2 Inhibitor10.9%Venclexta100%Part D≥25 patientsKinase inhibitor8.1%Jakafi70%Iclusig30%Part D<11 patients+ 4 more classes in this area
Nervous system
6.7%Phenothiazine4.4%Prochlorperazine Maleate100%Part D≥11 patientsSSRI2.2%Sertraline Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Ian Flinn, MD
Tennessee Oncology
Bipin Savani, MD
Tennessee Oncology
Lester Porter, MD
Tennessee Oncology
Annis Marney, MD, MSCI
Tennessee Oncology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”